Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 6
1984 7
1985 17
1986 20
1987 23
1988 32
1989 34
1990 46
1991 35
1992 40
1993 41
1994 40
1995 53
1996 45
1997 55
1998 53
1999 65
2000 70
2001 74
2002 83
2003 79
2004 53
2005 49
2006 51
2007 51
2008 49
2009 54
2010 45
2011 50
2012 51
2013 58
2014 76
2015 77
2016 66
2017 80
2018 69
2019 72
2020 67
2021 80
2022 69
2023 48
2024 58

Text availability

Article attribute

Article type

Publication date

Search Results

2,059 results

Results by year

Filters applied: . Clear all
Page 1
Rosacea: An Update in Diagnosis, Classification and Management.
Kang CN, Shah M, Tan J. Kang CN, et al. Skin Therapy Lett. 2021 Jul;26(4):1-8. Skin Therapy Lett. 2021. PMID: 34347259 Free article.
Evidence-based treatment recommendations include topical brimonidine and oxymetazoline for persistent erythema; topical azelaic acid, ivermectin, metronidazole, minocycline and oral doxycycline, tetracycline and isotretinoin for papules and pustules; vascular lasers and li …
Evidence-based treatment recommendations include topical brimonidine and oxymetazoline for persistent erythema; topical azelaic acid, …
Brimonidine.
Bakheit AH, Alomar AM, Darwish H, Alkahtani HM. Bakheit AH, et al. Profiles Drug Subst Excip Relat Methodol. 2023;48:1-37. doi: 10.1016/bs.podrm.2022.11.001. Epub 2023 Feb 24. Profiles Drug Subst Excip Relat Methodol. 2023. PMID: 37061271
Brimonidine is a highly selective 2-adrenoceptor agonist that lowers intraocular pressure (IOP) by decreasing aqueous humor production and increasing aqueous humor outflow via the uveoscleral route. Brimonidine is used to treat glaucoma and other eye conditions. …
Brimonidine is a highly selective 2-adrenoceptor agonist that lowers intraocular pressure (IOP) by decreasing aqueous humor productio …
S2k guideline: Rosacea.
Clanner-Engelshofen BM, Bernhard D, Dargatz S, Flaig MJ, Gieler U, Kinberger M, Klövekorn W, Kuna AC, Läuchli S, Lehmann P, Nast A, Pleyer U, Schaller M, Schöfer H, Steinhoff M, Schwennesen T, Werner RN, Zierhut M, Reinholz M. Clanner-Engelshofen BM, et al. J Dtsch Dermatol Ges. 2022 Aug;20(8):1147-1165. doi: 10.1111/ddg.14849. Epub 2022 Aug 5. J Dtsch Dermatol Ges. 2022. PMID: 35929658
For symptomatic treatment of persistent centrofacial erythema, the topical vasoconstrictors brimonidine or oxymetazoline can also be used. Systemic therapy is recommended for therapy-resistant and severe forms of rosacea papulopustulosa. ...
For symptomatic treatment of persistent centrofacial erythema, the topical vasoconstrictors brimonidine or oxymetazoline can also be …
Neurogenic Rosacea Treatment: A Literature Review.
Ivanic MG, Oulee A, Norden A, Javadi SS, Gold MH, Wu JJ. Ivanic MG, et al. J Drugs Dermatol. 2023 Jun 1;22(6):566-575. doi: 10.36849/JDD.7181. J Drugs Dermatol. 2023. PMID: 37276164 Review.
Combination treatments with topicals (eg, metronidazole, brimonidine), as well as oral medications including vascular (eg, beta blockers), psychiatric (eg, diazepam, duloxetine), neurologic (eg, pregabalin, sumatriptan), and antibiotic agents (eg, rifaximin), were often ci …
Combination treatments with topicals (eg, metronidazole, brimonidine), as well as oral medications including vascular (eg, beta block …
Post-acne erythema treatment: A systematic review of the literature.
Kalantari Y, Dadkhahfar S, Etesami I. Kalantari Y, et al. J Cosmet Dermatol. 2022 Apr;21(4):1379-1392. doi: 10.1111/jocd.14804. Epub 2022 Feb 3. J Cosmet Dermatol. 2022. PMID: 35076997 Review.
Topical treatments such as oxymetazoline, tranexamic acid, and brimonidine tartrate are promising treatments in reducing PAE lesions. In our study, no severe side effects were found. ...
Topical treatments such as oxymetazoline, tranexamic acid, and brimonidine tartrate are promising treatments in reducing PAE l …
Rosacea.
Maor D, Chong AH. Maor D, et al. Aust Fam Physician. 2017;46(5):277-281. Aust Fam Physician. 2017. PMID: 28472572 Free article.
Brimonidine as a possible treatment for myopia.
Peng Z, Xiang A, He H, Luo Y, Wu S, Luo Y, Yang J, Nie K, Zhong X. Peng Z, et al. BMC Ophthalmol. 2024 Apr 11;24(1):161. doi: 10.1186/s12886-024-03433-6. BMC Ophthalmol. 2024. PMID: 38605375 Free PMC article.
They were treated with 3 different methods of brimonidine administration (eye drops, and subconjunctival or intravitreal injections). Four different concentrations of brimonidine were tested for each method (2g/L, 4g/L, 20g/L, and 40g/L). ...RESULTS: Treatment with …
They were treated with 3 different methods of brimonidine administration (eye drops, and subconjunctival or intravitreal injections). …
Drugs, Inflammation, and the Eye.
Cunningham ET Jr, London NJ, Moorthy R, Garg SJ, Zierhut M. Cunningham ET Jr, et al. Ocul Immunol Inflamm. 2016;24(2):125-7. doi: 10.3109/09273948.2016.1160683. Ocul Immunol Inflamm. 2016. PMID: 27074544 No abstract available.
Difference in vasoconstrictors: oxymetazoline vs. brimonidine.
Okwundu N, Cline A, Feldman SR. Okwundu N, et al. J Dermatolog Treat. 2021 Mar;32(2):137-143. doi: 10.1080/09546634.2019.1639606. Epub 2019 Aug 12. J Dermatolog Treat. 2021. PMID: 31294643 Review.
OBJECTIVE: Topical oxymetazoline and brimonidine are the only medications approved for treating persistent facial erythema of rosacea. This review aims to investigate the efficacy, safety, pharmacodynamics, and pharmacokinetic properties of oxymetazoline and brimonidine …
OBJECTIVE: Topical oxymetazoline and brimonidine are the only medications approved for treating persistent facial erythema of rosacea …
Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments.
van Zuuren EJ, Fedorowicz Z, Tan J, van der Linden MMD, Arents BWM, Carter B, Charland L. van Zuuren EJ, et al. Br J Dermatol. 2019 Jul;181(1):65-79. doi: 10.1111/bjd.17590. Epub 2019 Mar 10. Br J Dermatol. 2019. PMID: 30585305 Free PMC article.
RESULTS: We included 152 studies (46 were new), comprising 20 944 participants. Topical interventions included brimonidine, oxymetazoline, metronidazole, azelaic acid, ivermectin and other topical treatments. ...CONCLUSIONS: For reducing temporarily persistent erythema the …
RESULTS: We included 152 studies (46 were new), comprising 20 944 participants. Topical interventions included brimonidine, oxymetazo …
2,059 results